Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | MPO | P05164 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | KDM5A | P29375 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | ALPL | P05186 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALPI | P09923 | 1/20 | 0.32 |
| ▸ | ALPG | P10696 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6022461 | 0.76 | — | — | |
| SCHEMBL347103 | 0.73 | LDHA (0.32) | BLMSMN1; SMN2 | |
| SCHEMBL11880209 | 0.71 | — | — | |
| SCHEMBL9959060 | 0.67 | — | — | |
| SCHEMBL11880200 | 0.67 | — | — | |
| SCHEMBL27775587 | 0.65 | MAPT (0.32) | MAPT | |
| SCHEMBL676346 | 0.64 | NR4A1 (0.35) | KDM4EALDH1A1MPOCYP3A4BLM | |
| SCHEMBL8586498 | 0.63 | CYP3A4 (0.46) | KDM4EALDH1A1CYP3A4SMN1; SMN2MAPT | |
| SCHEMBL2687724 | 0.62 | P2RX7 (0.38) | KDM4EALDH1A1MPOCYP3A4BLM | |
| SCHEMBL11128096 | 0.62 | PEPD (0.33) | ALDH1A1GFERMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230347016-A1 | VALVE MATERIAL WITH LONG-ACTING ANTITHROMBOSIS PROPERTY AND PREPARATION METHOD THEREFOR | VENUS MEDTECH (HANGZHOU) INC. (CN) | 2023-11-02 | — | — | US | claimed |
| EP-4137168-A1 | VALVE MATERIAL HAVING LONG-ACTING ANTITHROMBOSIS PROPERTY AND PREPARATION METHOD THEREFOR | Venus MedTech (HangZhou), Inc. (CN) | 2023-02-22 | — | — | EP | claimed |
| CN-112386695-B | Chitosan-based nano prodrug carrying indocyanine green and platinum drugs and preparation method thereof | 西安交通大学 | 2021-11-19 | — | — | CN | claimed |
| CN-112480289-B | Core-shell structure type chitosan-based nano prodrug carrying doxorubicin and platinum drugs together, and preparation method and application thereof | 西安交通大学 | 2021-09-07 | — | — | CN | claimed |
| CN-111658825-B | Valve material with long-acting antithrombotic performance and preparation method thereof | 四川大学 | 2021-03-30 | — | — | CN | claimed |
| CN-112480289-A | Core-shell structure type chitosan-based nano prodrug carrying doxorubicin and platinum drugs together, and preparation method and application thereof | 西安交通大学 | 2021-03-12 | — | — | CN | claimed |
| CN-112386695-A | Chitosan-based nano prodrug carrying indocyanine green and platinum drugs and preparation method thereof | 西安交通大学 | 2021-02-23 | — | — | CN | claimed |
| US-7667048-B2 | Green and orange fluorescent labels and their uses | ARIES ASSOCIATES, INC. (US) | 2010-02-23 | — | — | US | claimed |
| US-20080261235-A1 | Novel Green and Orange Fluorescent Labels and Their Uses | BHATT RAM | 2008-10-23 | — | — | US | claimed |
| EP-1303635-B1 | METHOD FOR THE SELECTIVE SURVIVAL OR SELECTIVE GROWTH OF A TARGET CELL BY THE USE OF A CONJUGATE, ITS USE IN THE THERAPEUTICS AND/OR DIAGNOSTICS | UNIV CATHOLIQUE LOUVAIN (BE) | 2007-02-21 | — | — | EP | claimed |
| EP-1546673-A4 | NOVEL GREEN AND ORANGE FLUORESCENT LABELS AND THEIR USES | CHROMAGEN INC (US) | 2006-08-09 | — | — | EP | claimed |
| US-6969593-B2 | Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in therapeutics and/or diagnostics and the preparation of said conjugate | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2005-11-29 | — | — | US | claimed |
| EP-1546673-A2 | NOVEL GREEN AND ORANGE FLUORESCENT LABELS AND THEIR USES | CHROMAGEN, INC. (US) | 2005-06-29 | — | — | EP | claimed |
| US-20040106806-A1 | Novel green and orange fluorescent labels and their uses | ARIES ASSOCIATES, INC. | 2004-06-03 | — | — | US | claimed |
| WO-2004027388-A2 | NOVEL GREEN AND ORANGE FLUORESCENT LABELS AND THEIR USES | CHROMAGEN, INC. (US) | 2004-04-01 | — | — | WO | claimed |
| US-20030099658-A1 | Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in therapeutics and/or diagnostics and the prepration of said conjugate | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2003-05-29 | — | — | US | claimed |
| US-20230347016-A1 | VALVE MATERIAL WITH LONG-ACTING ANTITHROMBOSIS PROPERTY AND PREPARATION METHOD THEREFOR | VENUS MEDTECH (HANGZHOU) INC. (CN) | 2023-11-02 | — | — | US | disclosed |
| CN-110049776-B | Immunogenic polysaccharide comprising conjugated protein derived from group B Streptococcus GBS polysaccharide | 辉瑞大药厂 | 2023-09-08 | — | — | CN | disclosed |
| US-5066789-A | Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages | NEORX CORPORATION (US) | 1991-11-19 | — | — | US | disclosed |
| WO-1990003401-A1 | TARGETING SUBSTANCE-DIAGNOSTIC/THERAPEUTIC AGENT CONJUGATES HAVING SCHIFF BASE LINKAGES | NEORX CORPORATION (US) | 1990-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106806-A1 | Novel green and orange fluorescent labels and their uses | CD69, ANXA5, ANXA6 | KDM4E 3408/4885ALDH1A1 2125/4885MPO 2795/4885 |
| US-20080261235-A1 | Novel Green and Orange Fluorescent Labels and Their Uses | CD69, ANXA6, ANXA5 | KDM4E 3665/4885ALDH1A1 1993/4885MPO 3030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.